HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Involvement of the thromboxane A2 receptor in the regulation of steroidogenic acute regulatory gene expression in murine Leydig cells.

Abstract
Recent studies suggested an involvement of thromboxane A2 in cyclooxygenase-2-dependent inhibition of steroidogenic acute regulatory (StAR) gene expression. The present study further investigated the role of thromboxane A2 receptor in StAR gene expression and steroidogenesis in testicular Leydig cells. The thromboxane A2 receptor was detected in several Leydig cell lines. Blocking thromboxane A2 binding to the receptor using specific antagonist SQ29548 or BM567 resulted in dose-dependent increases in StAR protein and steroid production in MA-10 mouse Leydig cells. The results were confirmed with Leydig cells isolated from rats. StAR promoter activity and StAR mRNA level in the cells were also increased after the treatments, suggesting an involvement of the thromboxane A2 receptor in StAR gene transcription. Furthermore study indicated that blocking the thromboxane A2 receptor reduced dosage sensitive sex reversal-adrenal hypoplasia congenita critical region on the X chromosome, gene 1 protein, a transcriptional repressor of StAR gene expression. Specific binding of the antagonists to the receptors on cellular membrane was demonstrated by binding assays using (3)H-SQ29548 and binding competition between (3)H-SQ29548 and BM567. Whereas SQ29548 enhanced cAMP-induced StAR gene expression, in the absence of cAMP, it was unable to increase StAR protein and steroidogenesis. However, when the receptor was blocked by the antagonist, subthreshold levels of cAMP were able to induce maximal levels of StAR protein expression, suggesting that blocking the thromboxane A2 receptor increase sensitivity of MA-10 cells to cAMP stimulation. Taken together, the results from the present and previous studies suggest an autocrine loop, involving cyclooxygenase-2, thromboxane A synthase, and thromboxane A2 and its receptor, in cyclooxygenase-2-dependent inhibition of StAR gene expression.
AuthorsAkhilesh K Pandey, Xiangling Yin, Randolph B Schiffer, James C Hutson, Douglas M Stocco, Paula Grammas, XingJia Wang
JournalEndocrinology (Endocrinology) Vol. 150 Issue 7 Pg. 3267-73 (Jul 2009) ISSN: 1945-7170 [Electronic] United States
PMID19325001 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • BM 567
  • Bridged Bicyclo Compounds, Heterocyclic
  • Fatty Acids, Unsaturated
  • Hydrazines
  • Phosphoproteins
  • Receptors, Thromboxane A2, Prostaglandin H2
  • Sulfonylurea Compounds
  • steroidogenic acute regulatory protein
  • Thromboxane A2
  • SQ 29548
  • Cyclooxygenase 2
  • Thromboxane-A Synthase
Topics
  • Animals
  • Bridged Bicyclo Compounds, Heterocyclic
  • Cell Line
  • Cyclooxygenase 2 (genetics)
  • Fatty Acids, Unsaturated
  • Gene Expression Regulation
  • Hydrazines (pharmacology)
  • Leydig Cells (metabolism)
  • Male
  • Mice
  • Phosphoproteins (genetics)
  • Rats
  • Receptors, Thromboxane A2, Prostaglandin H2 (physiology)
  • Sulfonylurea Compounds (pharmacology)
  • Thromboxane A2 (genetics, physiology)
  • Thromboxane-A Synthase (genetics, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: